U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H17F3N6O
Molecular Weight 306.2875
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ICI-162846

SMILES

NC(=O)CCCCN1C=CC(NC(=N)NCC(F)(F)F)=N1

InChI

InChIKey=ALCSGJCIESECFD-UHFFFAOYSA-N
InChI=1S/C11H17F3N6O/c12-11(13,14)7-17-10(16)18-9-4-6-20(19-9)5-2-1-3-8(15)21/h4,6H,1-3,5,7H2,(H2,15,21)(H3,16,17,18,19)

HIDE SMILES / InChI

Molecular Formula C11H17F3N6O
Molecular Weight 306.2875
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/1716826 | https://www.ncbi.nlm.nih.gov/pubmed/2903545 | https://www.ncbi.nlm.nih.gov/pubmed/18157166

ICI-162846 (5-((3- (N'- (2,2,2-trifluoroethyl)-guanidino)pyrazol-1-yl) valeramide) is a new histamine H2-receptor antagonist developed by Imperial Chemical Industries for treatment of peptic diseases. ICI-162846 shows the high degree of specificity for histamine H2-receptors and sustained inhibition of acid secretion.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
8.67 null [pKd]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Doses

Doses

DosePopulationAdverse events​
5 mg single, oral (unknown)
Highest studied dose
Dose: 5 mg
Route: oral
Route: single
Dose: 5 mg
Sources:
healthy
n = 10
Health Status: healthy
Sex: M
Food Status: FED
Population Size: 10
Sources:
PubMed

PubMed

TitleDatePubMed
Acid blockade by omeprazole or ICI 162846 in a chronic duodenal ulcer model.
1991 May
Patents

Sample Use Guides

Four ICI-162846 doses (0.5, 1.0, 2.5 and 5.0 mg) were given as a single tablet in randomized double-blind fashion
Route of Administration: Oral
Chinese hamster ovary (CHO) cells stably expressing a cyclic AMP response element-secreted placental alkaline phosphatase (CRE-SPAP) reporter gene were secondarily transfected with the human histamine H2 receptor. Cells were grown to confluence in 24-well plates. The media were removed and the cells pre-labelled for 3 h with 3H-adenine by incubation with 2 mCi/ml [3H]-adenine in serum-free media (0.5 ml per well). The 3H-adenine was removed and each well was washed by the addition and removal of 1ml serum-free media. Serum-free media (1 ml) containing 100 mM 3-isobutyl-1-methylxanthine (IBMX) with or without the final required concentration of antagonist were added to each well and the cells were incubated for 30 min. Agonist (in 10 ml serum-free media) was added to each well and the plates were incubated for 30 min. When the intrinsic activity of the antagonists was assessed, the ligands were incubated for 5 h in the presence of 100 mM IBMX to maximize the changes in 3H-cAMP accumulation. The reaction was terminated by the addition of 50 ml concentrated HCl per well. The plates were then frozen, thawed and 3H-cAMP was separated from other 3H-nucleotides by sequential Dowex and alumina column chromatography.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:50:43 GMT 2023
Edited
by admin
on Fri Dec 15 15:50:43 GMT 2023
Record UNII
SJ96DC9C66
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ICI-162846
Common Name English
1H-PYRAZOLE-1-PENTANAMIDE, 3-((IMINO((2,2,2-TRIFLUOROETHYL)AMINO)METHYL)AMINO)-
Systematic Name English
3-((IMINO((2,2,2-TRIFLUOROETHYL)AMINO)METHYL)AMINO)-1H-PYRAZOLE-1-PENTANAMIDE
Systematic Name English
ICI 162846
Code English
Code System Code Type Description
PUBCHEM
134778
Created by admin on Fri Dec 15 15:50:43 GMT 2023 , Edited by admin on Fri Dec 15 15:50:43 GMT 2023
PRIMARY
FDA UNII
SJ96DC9C66
Created by admin on Fri Dec 15 15:50:43 GMT 2023 , Edited by admin on Fri Dec 15 15:50:43 GMT 2023
PRIMARY
CAS
84545-30-2
Created by admin on Fri Dec 15 15:50:43 GMT 2023 , Edited by admin on Fri Dec 15 15:50:43 GMT 2023
PRIMARY
EPA CompTox
DTXSID5020734
Created by admin on Fri Dec 15 15:50:43 GMT 2023 , Edited by admin on Fri Dec 15 15:50:43 GMT 2023
PRIMARY